Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

BioMarin Pharmaceutical Inc. BMRN

Set alert

Price alert · BMRN

All alert types
57.44 USD -1.07 -1.83%

At close · Nov 2

55.02 -2.42 -4.21%

After hours · Nov 2, 4:00 PM ET

Bid
57.46 × 1
Ask
57.49 × 1
57.17 Day range 59.50
49.26 52-week range 70.98
YTD
-3.35%
1 year
+8.68%
Open
58.66
Prev close
58.51
Mkt cap
11.12B
Vol
3.26M
Avg vol
2.28M
EPS
0.36
P/E
159.56
Div yield
0.00%
More statistics
Low
57.17
High
59.50
Forward P/E
8.95
Beta
0.23
Short ratio
5.25
Inst. own
103.12%
Dividend
0.00
Ex-div date
Earnings
Feb 22, 2027
50-d avg
60.62
200-d avg
58.44
1y target
91.56

5D chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Nov 2, 2026Earnings: 0.23; estimate -0.08337; surprise 375.88%
Signals (131)
NameTimeAgo
SMA: BearishNov 2, 4:00 PM14 hours ago
SMA: BullishNov 2, 3:45 PM15 hours ago
SMA: BearishNov 2, 3:35 PM15 hours ago
MACD: Buy SignalNov 2, 3:30 PM15 hours ago
SMA: BullishNov 2, 3:25 PM15 hours ago
RSI: OversoldNov 2, 3:05 PM15 hours ago
RSI: OversoldNov 2, 2:35 PM16 hours ago
SMA: BearishNov 2, 1:45 PM17 hours ago
MACD: Sell SignalNov 2, 1:40 PM17 hours ago
SMA: BearishNov 2, 1:20 PM17 hours ago
SMA: BullishNov 2, 1:10 PM17 hours ago
SMA: BearishNov 2, 1:00 PM17 hours ago
SMA: BullishNov 2, 12:35 PM18 hours ago
SMA: BullishNov 2, 12:35 PM18 hours ago
SMA: BearishNov 2, 12:30 PM18 hours ago
SMA: BearishNov 2, 12:30 PM18 hours ago
SMA: BullishNov 2, 12:20 PM18 hours ago
SMA: BullishNov 2, 12:10 PM18 hours ago
SMA: BearishNov 2, 12:05 PM18 hours ago
MACD: Buy SignalNov 2, 11:45 AM19 hours ago

Newest 20 of 131.

Analyst view

Consensus: buy

Buy
Price target (mean) 91.56 +59.4% upside
Target (low)
60.00
Target (mean)
91.56
Target (high)
122.00
Ratings (0m) 28 21 buy · 7 hold · 0 sell
  • Strong buy5
  • Buy16
  • Hold7
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 28
  • 1 month ago 27
  • 2 months ago 27

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BMRN analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.1123-0.48 – 0.240.12-193.6%1.02B+31.8%15
Next quarter1.671.52 – 1.890.46+264.0%1.14B+30.5%12
Current year3.513.37 – 3.793.15+11.4%3.92B+21.8%15
Next year6.424.14 – 7.353.51+82.9%4.51B+14.9%13

Upgrades and downgrades

The latest rating changes

BMRN analyst upgrades and downgrades
DateFirmActionFromTo
Oct 21, 2026Morgan StanleyMaintainedOverweightOverweight
Oct 20, 2026JP MorganMaintainedOverweightOverweight
Oct 20, 2026Cantor FitzgeraldReiteratedOverweightOverweight
Oct 14, 2026BarclaysMaintainedOverweightOverweight
Sep 10, 2026HC Wainwright & Co.ReiteratedNeutralNeutral
Sep 1, 2026Piper SandlerMaintainedOverweightOverweight
Aug 31, 2026JefferiesMaintainedBuyBuy
Aug 31, 2026HC Wainwright & Co.MaintainedNeutralNeutral
Aug 19, 2026BMO CapitalInitiatedOutperformOutperform
Aug 18, 2026HC Wainwright & Co.MaintainedNeutralNeutral
Aug 17, 2026Piper SandlerMaintainedOverweightOverweight
Aug 17, 2026BarclaysMaintainedOverweightOverweight
Aug 10, 2026Canaccord GenuityMaintainedBuyBuy
Aug 7, 2026Morgan StanleyMaintainedOverweightOverweight
Aug 7, 2026OppenheimerMaintainedOutperformOutperform
Aug 7, 2026HC Wainwright & Co.MaintainedNeutralNeutral
Jul 16, 2026CitigroupMaintainedBuyBuy
Jul 7, 2026RBC CapitalMaintainedSector PerformSector Perform
May 22, 2026Canaccord GenuityMaintainedBuyBuy
May 19, 2026B of A SecuritiesMaintainedBuyBuy
May 19, 2026CitigroupInitiated—Buy
May 18, 2026HC Wainwright & Co.MaintainedNeutralNeutral
May 7, 2026Canaccord GenuityMaintainedBuyBuy
May 5, 2026BernsteinMaintainedOutperformOutperform
May 5, 2026Morgan StanleyMaintainedOverweightOverweight
May 5, 2026RBC CapitalReiteratedSector PerformSector Perform
May 5, 2026Evercore ISI GroupMaintainedOutperformOutperform
May 5, 2026HC Wainwright & Co.ReiteratedNeutralNeutral
Mar 11, 2026B of A SecuritiesMaintainedBuyBuy
Mar 4, 2026BarclaysMaintainedOverweightOverweight